Loading data for LABD — first visit, this takes a few seconds.
Direxion Daily S&P Biotec... (LABD)
NYSEArca: LABD
· Real-Time Price · USD
5.93
-1.27 (-17.64%)
At close: Aug 19, 2026, 3:25 PM
5.92
-0.17%
After-hours: 4:52 PM
Direxion Daily S&P Biotech Bear 3X Shares (LABD) Stock Price, Analysis & Data
-17.64% (1D)
| Bid | 5.95 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | n/a |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 5.93 |
| Volume | 26,917,724 |
| Avg. Volume (20D) | 10,814,069 |
| Open | 6.48 |
| Previous Close | 7.20 |
| Day's Range | 5.92 - 6.59 |
| 52-Week Range | 5.92 - 60.90 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LABD
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. T...
Industry n/a
Sector n/a
IPO Date May 28, 2015
Employees n/a
Stock Exchange NYSEArca
Ticker Symbol LABD
Financial Performance
In undefined, Direxion Daily S&P Biotech Bear 3X Shares's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements
